The virtual edition of the 25th European Hematology Association (EHA) Annual Congress will bring together subject matter experts for a 10-day program to discuss the latest news in hematology and its subspecialties, new evidence-based approaches to diagnosis and treatment and unpublished clinical and translational research results, innovative techniques, diagnostic tools, and risk-assessment strategies.

Members from Evidera’s Modeling & Simulation team will be presenting an ePoster titled, “Comparison of Safety Management Costs across Chimeric Antigen Receptor (CAR) T Cell Therapies in Relapsed or Refractory Large B-Cell Lymphoma.” Authors include: Rivolo S, Xiao Y, Litkiewicz M, Saint-Laurent Thibault C, Patel L, Zhang Y, Dorman E, Liu F, Kuruvilla J.

Conference Website